News

Vaccination offers hope ... if we only take the chance.

Study examining the role of IL-17A in patients with diabetes.

Rapid test allows healthcare professionals to make fast decisions at the point of care.

Investigators are studying the use of photobiomodulation in the treatment of dry age-related macular degeneration.

Following a successful Phase 2 study, a Phase 2/3 clinical trial for the compound is currently planned for mid-2021.

Investigators focus on biophysical method to study protein-protein interactions .

While current treatments are good, the best is yet to come.

Investigators from the University of Pittsburgh and West Virginia University will collaborate on an international glaucoma laser study funded with a combined $15.2 million grant.

Paul S. Bernstein, MD, PhD, leads a team of University of Utah investigators that has developed a method for synthesizing large enough quantities of very-long-chain polyunsaturated fatty acids to evaluate their potential sight-preserving properties.

Intraocular drainage surgery may have a future for treating issues.

Consider ideas about outflow pathways, neuroprotection.

Investigators examine long-term effects of therapeutics in infants.

The American Society of Cataract and Refractive Surgery has changed the venue for its 2021 annual meeting. The conference will now be held July 23-27 at the Mandalay Bay Convention Center in Las Vegas.

Daniel H. Chang, MD, shares data on a recent study involving a new violet light-filtering chromophore in a preclinical computer simulation testing and randomized clinical study.

Bascom Palmer Eye Institute will hold its 18th annual meeting, titled Angiogenesis, Exudation, and Degeneration 2021, a virtual event set for February 12-13.

Peptides offering ophthalmologists a potential treatment option for keratitis.

Phakic lenses are proving to be excellent additions to refractive practices.

Check out the latest cartoon!

Fellows, residents from around the world show promise for future of retinal research.

The study focused the safety and tolerability of increasing doses of polihexanide eye drops in order to choose a dose that would be tested in a phase III clinical trial in patients with acanthamoeba keratitis.

Once-daily corticosteroid treats pain, inflammation after surgery.

Results of a survey among ophthalmologists indicate that patients are receiving fewer examinations — with worsening glaucoma, says S. Fabian Lerner, MD, speaking at the Glaucoma 360 New Horizons Forum.

A new therapy provides noninvasive nighttime IOP control by programming the desired pressure into the device, explained John Berdahl, MD, during the New Horizons Forum.

Noninvasive option reduces IOP in patients with glaucoma.

Investigators at the Wilmer Eye Institute at the Johns Hopkins University School of Medicine conducting experiments in mouse tissues and human cells found that they may be able improve the success rate for regrowing nerve cells damaged by blinding diseases.

The Phase 1 clinical trial of EyePoint Pharmaceuticals Inc.’s EYP-1901 is underway. It is a potential twice-yearly sustained delivery anti-VEGF treatment targeting wet age-related macular degeneration.

Community involvement, research continue to boost treatment in pediatric population.

According to investigators, a lack of definitive knowledge about the presence of SARS-CoV-2 in corneal tissues has resulted in the recommendation to avoid using corneal tissue for transplantation when the tissue was obtained from donors with COVID-19 that had been confirmed or those who were exposed to COVID-19.